Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

27 August 2021 (11:03 - 11:15)
Organised by:
Congress Presentation Part of: Late Breaking Trials in ACS Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo

The Second Xiangya Hospital of Central South University, Changsha (China)

The Event

ESC 365 is supported by

ESC 365 is supported by